BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 25784941)

  • 1. CXCL13 Promotes Osteogenic Differentiation of Mesenchymal Stem Cells by Inhibiting miR-23a Expression.
    Tian F; Ji XL; Xiao WA; Wang B; Wang F
    Stem Cells Int; 2015; 2015():632305. PubMed ID: 25784941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Icariin regulates miR-23a-3p-mediated osteogenic differentiation of BMSCs via BMP-2/Smad5/Runx2 and WNT/β-catenin pathways in osteonecrosis of the femoral head.
    Zhang XY; Li HN; Chen F; Chen YP; Chai Y; Liao JZ; Gan B; Chen DP; Li S; Liu YQ
    Saudi Pharm J; 2021 Dec; 29(12):1405-1415. PubMed ID: 35002378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteogenic growth peptide promotes osteogenic differentiation of mesenchymal stem cells mediated by LncRNA AK141205-induced upregulation of CXCL13.
    Li H; Zhang Z; Chen Z; Zhang D
    Biochem Biophys Res Commun; 2015 Oct; 466(1):82-8. PubMed ID: 26321662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CXCL13 promotes the effect of bone marrow mesenchymal stem cells (MSCs) on tendon-bone healing in rats and in C3HIOT1/2 cells.
    Tian F; Ji XL; Xiao WA; Wang B; Wang F
    Int J Mol Sci; 2015 Jan; 16(2):3178-87. PubMed ID: 25647417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High glucose prevents osteogenic differentiation of mesenchymal stem cells via lncRNA AK028326/CXCL13 pathway.
    Cao B; Liu N; Wang W
    Biomed Pharmacother; 2016 Dec; 84():544-551. PubMed ID: 27693963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. microRNA-23a inhibits osteogenic differentiation of human bone marrow-derived mesenchymal stem cells by targeting LRP5.
    Li T; Li H; Wang Y; Li T; Fan J; Xiao K; Zhao RC; Weng X
    Int J Biochem Cell Biol; 2016 Mar; 72():55-62. PubMed ID: 26774446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of p53 mediated miR-23a/CXCL12 pathway in osteogenic differentiation of bone mesenchymal stem cells on nanostructured titanium surfaces.
    Zhuang XM; Zhou B; Yuan KF
    Biomed Pharmacother; 2019 Apr; 112():108649. PubMed ID: 30784930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of miR-339 promotes differentiation of BMSCs and alleviates osteoporosis by targeting DLX5.
    Zhou J; Nie H; Liu P; Wang Z; Yao B; Yang L
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):29-36. PubMed ID: 30657543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA MEG3 inhibited osteogenic differentiation of bone marrow mesenchymal stem cells from postmenopausal osteoporosis by targeting miR-133a-3p.
    Wang Q; Li Y; Zhang Y; Ma L; Lin L; Meng J; Jiang L; Wang L; Zhou P; Zhang Y
    Biomed Pharmacother; 2017 May; 89():1178-1186. PubMed ID: 28320084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-664a-5p promotes osteogenic differentiation of human bone marrow-derived mesenchymal stem cells by directly downregulating HMGA2.
    Zhang Y; Liu Y; Wu M; Wang H; Wu L; Xu B; Zhou W; Fan X; Shao J; Yang T
    Biochem Biophys Res Commun; 2020 Jan; 521(1):9-14. PubMed ID: 31630797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CXCL13 inhibits microRNA-23a through PI3K/AKT signaling pathway in adipose tissue derived-mesenchymal stem cells.
    Li ZW; Zhao L; Han QC; Zhu X
    Biomed Pharmacother; 2016 Oct; 83():876-880. PubMed ID: 27509223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of miR-34c-5p in Osteogenic Differentiation of Bone Marrow Mesenchymal Stem Cells.
    Liu B; Gan W; Jin Z; Wang M; Cui G; Zhang H; Wang H
    Int J Stem Cells; 2021 Aug; 14(3):286-297. PubMed ID: 33906980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of miR-103 by negatively regulating SATB2 on proliferation and osteogenic differentiation of human bone marrow mesenchymal stem cells.
    Lv H; Yang H; Wang Y
    PLoS One; 2020; 15(5):e0232695. PubMed ID: 32379794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA expression profiling of human bone marrow mesenchymal stem cells during osteogenic differentiation reveals Osterix regulation by miR-31.
    Baglìo SR; Devescovi V; Granchi D; Baldini N
    Gene; 2013 Sep; 527(1):321-31. PubMed ID: 23827457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-related CXC chemokine receptor-4-deficiency impairs osteogenic differentiation potency of mouse bone marrow mesenchymal stromal stem cells.
    Guang LG; Boskey AL; Zhu W
    Int J Biochem Cell Biol; 2013 Aug; 45(8):1813-20. PubMed ID: 23742988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIF-1α-TWIST pathway restrains cyclic mechanical stretch-induced osteogenic differentiation of bone marrow mesenchymal stem cells.
    Liu Y; Huang X; Yu H; Yang J; Li Y; Yuan X; Guo Q
    Connect Tissue Res; 2019 Nov; 60(6):544-554. PubMed ID: 30938209
    [No Abstract]   [Full Text] [Related]  

  • 17. Decrease of MiR-31 induced by TNF-α inhibitor activates SATB2/RUNX2 pathway and promotes osteogenic differentiation in ethanol-induced osteonecrosis.
    Yu L; Xu Y; Qu H; Yu Y; Li W; Zhao Y; Qiu G
    J Cell Physiol; 2019 Apr; 234(4):4314-4326. PubMed ID: 30132874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA HULC promotes proliferation and osteogenic differentiation of bone mesenchymal stem cells via down-regulation of miR-195.
    Jiang XR; Guo N; Li XQ; Yang HY; Wang K; Zhang CL; Li GS; Li GD
    Eur Rev Med Pharmacol Sci; 2018 May; 22(10):2954-2965. PubMed ID: 29863237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of microRNA-23b in TNF-α-reduced BMSC osteogenic differentiation via targeting runx2.
    Deng L; Hu G; Jin L; Wang C; Niu H
    J Bone Miner Metab; 2018 Nov; 36(6):648-660. PubMed ID: 29234953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-503-5p inhibits stretch-induced osteogenic differentiation and bone formation.
    Liu L; Liu M; Li R; Liu H; Du L; Chen H; Zhang Y; Zhang S; Liu D
    Cell Biol Int; 2017 Feb; 41(2):112-123. PubMed ID: 27862699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.